Avidian Wealth Solutions LLC Purchases 171 Shares of The Procter & Gamble Company (NYSE:PG)

Avidian Wealth Solutions LLC increased its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 1.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,492 shares of the company’s stock after acquiring an additional 171 shares during the period. Avidian Wealth Solutions LLC’s holdings in Procter & Gamble were worth $2,417,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of PG. Hexagon Capital Partners LLC raised its position in shares of Procter & Gamble by 0.7% in the third quarter. Hexagon Capital Partners LLC now owns 10,058 shares of the company’s stock valued at $1,467,000 after purchasing an additional 74 shares during the period. Cambridge Investment Research Advisors Inc. grew its position in shares of Procter & Gamble by 3.7% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 629,247 shares of the company’s stock valued at $91,782,000 after purchasing an additional 22,454 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in shares of Procter & Gamble by 0.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 2,520,789 shares of the company’s stock valued at $367,682,000 after purchasing an additional 10,090 shares during the period. Xponance Inc. lifted its holdings in Procter & Gamble by 3.4% during the 3rd quarter. Xponance Inc. now owns 335,580 shares of the company’s stock worth $48,948,000 after purchasing an additional 11,035 shares in the last quarter. Finally, Joel Isaacson & Co. LLC boosted its stake in Procter & Gamble by 1.6% in the 3rd quarter. Joel Isaacson & Co. LLC now owns 65,135 shares of the company’s stock worth $9,501,000 after purchasing an additional 1,025 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PG. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a report on Wednesday, January 24th. Jefferies Financial Group raised their price target on shares of Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a report on Monday, April 22nd. Raymond James upped their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Argus boosted their target price on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. Finally, Royal Bank of Canada raised their price target on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $169.76.

Get Our Latest Stock Analysis on PG

Procter & Gamble Stock Up 0.4 %

Shares of PG stock traded up $0.62 during mid-day trading on Friday, hitting $164.46. The company’s stock had a trading volume of 5,581,692 shares, compared to its average volume of 6,941,715. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $164.71. The stock has a market cap of $388.15 billion, a price-to-earnings ratio of 26.87, a PEG ratio of 3.33 and a beta of 0.43. The business has a 50-day moving average price of $160.01 and a 200 day moving average price of $154.17.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter last year, the firm posted $1.37 EPS. The business’s quarterly revenue was up .6% compared to the same quarter last year. Research analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. The ex-dividend date is Thursday, April 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.45%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Insider Buying and Selling

In other news, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total value of $620,719.00. Following the completion of the sale, the insider now directly owns 11,886 shares in the company, valued at approximately $1,908,891.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, COO Shailesh Jejurikar sold 31,000 shares of the stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $162.90, for a total value of $5,049,900.00. Following the completion of the sale, the chief operating officer now directly owns 9,739 shares of the company’s stock, valued at $1,586,483.10. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 3,865 shares of Procter & Gamble stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the transaction, the insider now owns 11,886 shares in the company, valued at approximately $1,908,891.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 86,865 shares of company stock valued at $14,059,180. 0.17% of the stock is owned by insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.